Herantis Pharma to Participate in Redeye Growth Day in June
Herantis Pharma Plc, Press Release, 27 May 2022 at 13:00 EEST Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that interim CEO Frans Wuite will be presenting at the Redeye Growth Day on June 2th, 2022. Redeye Growth Day The presentation will be live on the Redeye platform at 9:25 a.m. CEST Follow this link to the event: Redeye Growth Day. The presentations will be available via digital libraries, which are accessible to event participants